FDA staff review questions efficacy of Merck's C. difficile drug

June 7 (Reuters) - A preliminary review by the U.S. Food and

Drug Administration of Merck & Co.'s experimental drug to

treat the most common cause of health care-associated infectious

diarrhea...

Read more